The conference will be held November 3-4, 2009 at the Waldorf Astoria in New York City
By Militza Richard
The Oppenheimer 20th Annual Healthcare Conference will present a core group of public and private companies who are leading the healthcare industry, including pioneers in the pharmaceutical, biotechnology, medical device, healthcare facility, health technology and distribution, provider and service industries.
“Over 19 years, the Oppenheimer Healthcare Conference has become a highly valuable investor conference in this sector. Through formal company presentations and panels, attendees will gain insight from, and access to, industry leaders,” says the official website.
Companies attending the conference will address issues such as health reform, Medicare and Medicaid, generic drug regulation, development of new blockbuster pharmaceutical and biotechnology products, product safety and patent issues, cross-border reimportation, Food and Drug Administration policy, managed care, and the current M&A environment.
Several prominent companies have recently pledged attendance. Biodel Inc. (Nasdaq: BIOD), a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders, today announced that Dr. Solomon Steiner, Chairman and CEO of Biodel, will present a corporate update at the at the conference on November 3rd, 2009 at 9:40 a.m. ET.
MEDNAX Inc.’s Chief Executive Officer, Roger J. Medel, M.D. will present on Tuesday at 10:50 a.m. while Gilead Sciences, Inc. (Nasdaq:GILD) announced that Patrick O’Brien, Gilead’s Director, Investor Relations will also be providing an overview of his company on Tuesday at 10:50 a.m.
Health Management Associates, Inc. (NYSE:HMA), which owns and operates 54 hospitals, will give its presentation on Tuesday, November 3, 2009 at 1:35 p.m.
AMRI (NASDAQ: AMRI) announced that AMRI Director of Investor Relations Peter Jerome will present on Tuesday, November 3, 2009 at 3:20 p.m.
Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) is scheduled to make an investor presentation. David Seltzer, President and Chief Executive Officer, will deliver the Company's presentation on Tuesday at 3:55 p.m.
Edited by Gabe Perna